Skip to main content
Oxford Biomedica plc (LON:OXB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
624.00
-14.00 (-2.19%)
At close: Mar 6, 2026

Oxford Biomedica Revenue

Oxford Biomedica had revenue of 73.22M GBP in the half year ending June 30, 2025, with 70.04% growth. This brings the company's revenue in the last twelve months to 151.21M, up 55.44% year-over-year. In the year 2024, Oxford Biomedica had annual revenue of 128.80M with 43.84% growth.

Revenue (ttm)
151.21M
Revenue Growth
+55.44%
P/S Ratio
4.99
Revenue / Employee
168.02K
Employees
900
Market Cap
754.25M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024128.80M39.26M43.84%
Dec 31, 202389.54M-50.45M-36.04%
Dec 31, 2022139.99M-2.81M-1.97%
Dec 31, 2021142.80M55.07M62.77%
Dec 31, 202087.73M23.67M36.95%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oxford Nanopore Technologies 223.90M
Genus 672.00M
PureTech Health 4.66M
Avacta Group 113.00K
Scancell Holdings 4.71M
4basebio 1.78M
Bioventix 13.12M
Faron Pharmaceuticals Oy 1.14M
Revenue Rankings

Oxford Biomedica News

More News